| NDC Code | 43742-1432-1 |
|---|
| Package Description | 960 mL in 1 PACKAGE (43742-1432-1) |
|---|
| Product NDC | 43742-1432 |
|---|
| Product Type Name | DRUG FOR FURTHER PROCESSING |
|---|
| Non-Proprietary Name | Coxsackie A2, A7, B1, B3, B4 |
|---|
| Dosage Form | LIQUID |
|---|
| Start Marketing Date | 20190213 |
|---|
| End Marketing Date | 20240424 |
|---|
| Marketing Category Name | DRUG FOR FURTHER PROCESSING |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B3 |
|---|
| Strength | 250; 250; 250; 250; 250 |
|---|
| Strength Unit | [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
|---|